KCT0007832
Recruiting
未知
A 8 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Angelica gigas N. extract powder(Nutragen) on immune enhancement
ConditionsDiseases of the respiratory system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the respiratory system
- Sponsor
- Jeonbuk National University Hospital
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Male and female aged 19 or over and 75 or under at the screening examination
- •2\) Participants who had symptoms of upper respiratory infection (cold, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, rhinitis, etc.) at least twice within 12 months before screening examination
- •3\) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions
Exclusion Criteria
- •1\) Patients who have received vaccination) within two months before ingestion date of investigational product
- •2\) Patients whose BMI is 18\.5 kg/m2 under or 35 kg/m2 or over at the screening examination
- •3\) Patients who have clinically significant acute or chronic cardio\-cerebrovascular systems, endocrine systems, immune systems, respiratory systems, hepatic biliary systems, kidneys and urinary systems, neuropsychiatric systems, musculoskeletal systems, inflammatory and hematologic and tumorigenic, gastrointestinal diseases, etc.
- •4\) Those who took medicines and health functional foods related to immunity enhancement within one month before the screening examination (refer to combination prohibited drugs)
- •5\) Patients with a history of significant hypersensitivity reaction to the ingredients of Angelica gigas
- •6\) Patients who have received anti\-psychotic medication within three months before the screening examination
- •7\) Patients who have or are suspected of alcoholism or substance abuse
- •8\) Patients participated in another clinical trial within three months before the screening examination
- •9\) Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A human trial to evaluate the efficacy and safety of Echinacea extract on promotion of immunity enhancementKCT0006531Wonkwang University. Iksan Korean Medicine Hospital80
Not yet recruiting
Not Applicable
Clinical trial to evaluate the efficacy and safety of SH003 of immunity functioDiseases of the respiratory systemKCT0009424Jaein R&P120
Recruiting
Not Applicable
the efficacy and safety of Triticum aestivum L. sprout extract on improvement of Liver functioDiseases of the digestive systemKCT0007271Woosuk University Korean Medicine Medical Center100
Recruiting
Not Applicable
A human trail of Saccaharum Officinalis L. wax alcohols(Policosanol) on improvement of blood cholesterolEndocrine, nutritional and metabolic diseasesKCT0008540Wonkwang University, Gwangju Medical Center100
Recruiting
Not Applicable
APGP for the evaluation of efficacy on immune function and immune cell activatioNot ApplicableKCT0002551Yonsei University100